Russell Investments Group Ltd. Acquires 350 Shares of Atrion Co. (NASDAQ:ATRI)

Russell Investments Group Ltd. lifted its position in shares of Atrion Co. (NASDAQ:ATRI) by 11.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 3,323 shares of the medical instruments supplier’s stock after buying an additional 350 shares during the period. Russell Investments Group Ltd. owned 0.18% of Atrion worth $2,233,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of ATRI. Schwab Charles Investment Management Inc. increased its position in Atrion by 0.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 6,183 shares of the medical instruments supplier’s stock worth $3,978,000 after purchasing an additional 19 shares during the last quarter. Bank of New York Mellon Corp increased its position in Atrion by 0.7% during the second quarter. Bank of New York Mellon Corp now owns 10,258 shares of the medical instruments supplier’s stock worth $6,600,000 after purchasing an additional 76 shares during the last quarter. Legal & General Group Plc increased its position in Atrion by 4.3% during the second quarter. Legal & General Group Plc now owns 336 shares of the medical instruments supplier’s stock worth $216,000 after purchasing an additional 14 shares during the last quarter. BNP Paribas Arbitrage SA increased its position in Atrion by 4,800.0% during the second quarter. BNP Paribas Arbitrage SA now owns 196 shares of the medical instruments supplier’s stock worth $126,000 after purchasing an additional 192 shares during the last quarter. Finally, Victory Capital Management Inc. increased its position in Atrion by 17.7% during the second quarter. Victory Capital Management Inc. now owns 438 shares of the medical instruments supplier’s stock worth $282,000 after purchasing an additional 66 shares during the last quarter. 59.01% of the stock is owned by hedge funds and other institutional investors.

Separately, BidaskClub lowered shares of Atrion from a “sell” rating to a “strong sell” rating in a research report on Tuesday.

Shares of Atrion Co. (NASDAQ:ATRI) traded down $9.10 during mid-day trading on Friday, reaching $584.35. 2,184 shares of the company traded hands, compared to its average volume of 3,474. Atrion Co. has a 1 year low of $454.10 and a 1 year high of $694.00. The firm has a market capitalization of $1,098.98, a price-to-earnings ratio of 32.37 and a beta of 0.85.

Atrion (NASDAQ:ATRI) last issued its quarterly earnings results on Wednesday, November 8th. The medical instruments supplier reported $4.29 EPS for the quarter. Atrion had a net margin of 22.98% and a return on equity of 18.34%. The firm had revenue of $37.90 million during the quarter.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 15th. Stockholders of record on Friday, December 1st were given a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend was Thursday, November 30th. Atrion’s payout ratio is currently 26.59%.

ILLEGAL ACTIVITY WARNING: “Russell Investments Group Ltd. Acquires 350 Shares of Atrion Co. (NASDAQ:ATRI)” was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.thelincolnianonline.com/2018/01/13/russell-investments-group-ltd-has-2-23-million-position-in-atrion-co-atri-updated-updated.html.

About Atrion

Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.

Institutional Ownership by Quarter for Atrion (NASDAQ:ATRI)

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply